Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cosby, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cosby, R. S.
(Chest. 1963;44:251-257.)
© 1963 American College of Chest Physicians

The Intermediate Coronary Syndrome

Richard S. Cosby M.D., F.C.C.P.1

1 Associate Clinical Professor of Medicine, University of Southern California School of Medicine

1. Forty-seven patients with the intermediate coronary artery syndrome have been etiologically divided into six subgroups, depending upon the presence or absence of heart disease, and the precipitating factors. Each subclassification varies in course, prognosis, therapy and significance.

2. Although etiologically diverse, certain basic electrocardiographic criteria define the entire group. There are two patterns, both more frequent over the anterior and lateral surface of the heart; (a) the more frequent T wave inversion, and (b) the less frequent ST and J point depression with lowered T wave. Anterior ST and J point depression is usually accompanied by elevation of ST in AVR. Continuous cyclic progression and regression is the rule over a time period of ten days to two weeks.

3. The prognosis is impossible to ascertain at the start of the attack. It depends largely upon the underlying heart disease, and the SGO-T is almost always within the normal range.

4. Because of the difficulties in prognosis and the frequency of underlying serious heart disease, early and long-term anticoagulant therapy should be considered the therapy of choice at this time.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1963 by the American College of Chest Physicians.